COUP-TFII controls mouse pancreatic β-cell mass through GLP-1-β-catenin signaling pathways

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Boutant, Marie ^a,b,c,i   Ramos, Oscar Henrique Pereira ^a,b,c,d   Tourrel Cuzin, Cécile ^a,b,c   Movassat, Jamileh ^d   Ilias, Anissa ^d   Vallois, David ^e   Planchais, Julien ^a,b,c   Pégorier, Jean Paul ^a,b,c   Schuit, Frans ^f   Petit, Patrice X ^b   Bossard, Pascale ^a,b,c   Maedler, Kathrin ^h   Grapin Botton, Anne ^g   Vasseur Cognet, Mireille ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Groupe Hospitalier Pitié Salpêtrière   (France)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

^f Department of Molecular Cellular Biology ^*  (Belgium)

^g EPFL   (Switzerland)

^h UNIVERSITY OF BREMEN   (Germany)

ⁱ SERVICE DE CHIMIE BIOORGANIQUE ET DE MARQUAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; AXIN 2 PROTEIN; BETA CATENIN; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; CRE RECOMBINASE; CYCLIN D1; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INSULIN; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG; NR2F2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; GLUCOSE INTOLERANCE; MALE; MOUSE; NEWBORN PERIOD; NONHUMAN; PANCREAS ISLET BETA CELL; PERINATAL PERIOD; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY; ANIMAL; ANIMAL EMBRYO; BIOLOGICAL MODEL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; NEWBORN; ORGAN SIZE; PANCREAS; PHYSIOLOGY; PRENATAL DEVELOPMENT; RAT; TRANSGENIC MOUSE;

MUS; RATTUS;

ANIMALS; ANIMALS, NEWBORN; BETA CATENIN; CELL COUNT; CELLS, CULTURED; COUP TRANSCRIPTION FACTOR II; EMBRYO, MAMMALIAN; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN-SECRETING CELLS; MALE; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; ORGAN SIZE; PANCREAS; RATS; SIGNAL TRANSDUCTION;

EID: 84856182332     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030847     Document Type: Article

References (60)

1. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, et al. (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110.
2. Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, et al. (2006) International Union of Pharmacology. LXVI. Orphan nuclear receptors. PharmacolRev 58: 798-836.
3. Bardoux P, Zhang P, Flamez D, Perilhou A, Lavin T, et al. (2005) Essential role of chicken ovalbumin upstream promoter-transcription factor II in insulin secretion and insulin sensitivity revealed by conditional gene knockout. Diabetes pp. 1357-1363.
4. Perilhou A, Tourrel-Cuzin C, Zhang P, Kharroubi I, Wang H, et al. (2008) MODY1 gene HNF4α and a feedback loop control COUP-TFII expression in the pancreatic beta cells. Mol Cell Biol 28: 4588-4597.
5. Perilhou A, Tourrel-Cuzin C, Kharroubi I, Henique C, Fauveau V, et al. (2008) The transcription factor COUP-TFII is negatively regulated by insulin and glucose via FoxO1 and ChREBP controlled pathways. Mol Cell Biol 28: 6568-6579.
6. Willert K, Jones KA, (2006) Wnt signaling: is the party in the nucleus? Genes Dev 20: 1394-1404.
7. Figeac F, Uzan B, Faro M, Chelali N, Portha B, et al. (2010) Neonatal growth and regeneration of {beta} cells are regulated by the Wnt/{beta}-catenin signaling in normal and diabetic rats. Am J Physiol Endocrinol Metab 298: E245-256.
8. Schafer SA, Tschritter O, Machicao F, Thamer C, Stefan N, et al. (2007) Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 50: 2443-2450.
9. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, et al. (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117: 2155-2163.
10. Nauck MA, Meier JJ, (2007) The enteroinsular axis may mediate the diabetogenic effects of TCF7L2 polymorphisms. Diabetologia 50: 2413-2416.
11. Liu Z, Habener JF, (2010) Wnt signaling in pancreatic islets. Adv Exp Med Biol 654: 391-419.
12. Rulifson IC, Karnik SK, Heiser PW, ten Berge D, Chen H, et al. (2007) Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci U S A 104: 6247-6252.
13. Heiser PW, Lau J, Taketo MM, Herrera PL, Hebrok M, (2006) Stabilization of beta-catenin impacts pancreas growth. Development 133: 2023-2032.
14. Dessimoz J, Bonnard C, Huelsken J, Grapin-Botton A, (2005) Pancreas-specific deletion of beta-catenin reveals Wnt-dependent and Wnt-independent functions during development. Curr Biol 15: 1677-1683.
15. Murtaugh LC, Law AC, Dor Y, Melton DA, (2005) Beta-catenin is essential for pancreatic acinar but not islet development. Development 132: 4663-4674.
16. Welters HJ, Kulkarni RN, (2008) Wnt signaling: relevance to beta-cell biology and diabetes. Trends Endocrinol Metab 19: 349-355.
17. Liu Z, Habener JF, (2008) Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J Biol Chem 283: 8723-8735.
18. Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, et al. (2002) Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143: 4397-4408.
19. Li Y, Hansotia T, Yusta B, Ris F, Halban PA, et al. (2003) Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J Biol Chem 278: 471-478.
20. Cornu M, Yang JY, Jaccard E, Poussin C, Widmann C, et al. (2009) Glucagon-like peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop. Diabetes 58: 1816-1825.
21. Xu G, Stoffers DA, Habener JF, Bonner-Weir S, (1999) Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48: 2270-2276.
22. Tourrel C, Bailbe D, Meile MJ, Kergoat M, Portha B, (2001) Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 50: 1562-1570.
23. Tourrel C, Bailbe D, Lacorne M, Meile MJ, Kergoat M, et al. (2002) Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 51: 1443-1452.
24. Kwon DY, Kim YS, Ahn IS, Kim da S, Kang S, et al. (2009) Exendin-4 potentiates insulinotropic action partly via increasing beta-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats. J Pharmacol Sci 111: 361-371.
25. Gu G, Dubauskaite J, Melton D, (2002) Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129: 2447-2457.
26. Chen C, Fang R, Davis C, Maravelias C, Sibley E, (2009) Pdx1 inactivation restricted to the intestinal epithelium in mice alters duodenal gene expression in enterocytes and enteroendocrine cells. Am J Physiol Gastrointest Liver Physiol 297: G1126-1137.
27. Zhang P, Bennoun M, Godard C, Bossard P, Leclerc I, et al. (2002) Expression of COUP-TFII in metabolic tissues during development. Mech Dev 119: 109-114.
28. Ackermann AM, Gannon M, (2007) Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J Mol Endocrinol 38: 193-206.
29. Inada A, Nienaber C, Katsuta H, Fujitani Y, Levine J, et al. (2008) Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc Natl Acad Sci U S A 105: 19915-19919.
30. Kopp JL, Dubois CL, Schaffer AE, Hao E, Shih HP, et al. (2011) Sox9+ ductal cells are multipotent progenitors throughout development but do not produce new endocrine cells in the normal or injured adult pancreas. Development 138: 653-665.
31. Petit PX, Lecoeur H, Zorn E, Dauguet C, Mignotte B, et al. (1995) Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 130: 157-167.
32. Okamura M, Kudo H, Wakabayashi K, Tanaka T, Nonaka A, et al. (2009) COUP-TFII acts downstream of Wnt/beta-catenin signal to silence PPARgamma gene expression and repress adipogenesis. Proc Natl Acad Sci U S A 106: 5819-5824.
33. Li L, Xie X, Qin J, Jeha GS, Saha PK, et al. (2009) The nuclear orphan receptor COUP-TFII plays an essential role in adipogenesis, glucose homeostasis, and energy metabolism. Cell Metab 9: 77-87.
34. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J, et al. (2008) Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 57: 645-653.
35. Sauter NS, Schulthess FT, Galasso R, Castellani LW, Maedler K, (2008) The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology 149: 2208-2218.
36. Xu Z, Yu S, Hsu CH, Eguchi J, Rosen ED, (2008) The orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II is a critical regulator of adipogenesis. Proc Natl Acad Sci U S A 105: 2421-2426.
37. Kim BJ, Takamoto N, Yan J, Tsai SY, Tsai MJ, (2009) Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) regulates growth and patterning of the postnatal mouse cerebellum. Dev Biol 326: 378-391.
38. Lin FJ, Chen X, Qin J, Hong YK, Tsai MJ, et al. (2009) Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J Clin Invest 120: 1694-1707.
39. Drucker DJ, Nauck MA, (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368: 1696-1705.
40. Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, et al. (2003) cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 17: 1575-1580.
41. Buteau J, Roduit R, Susini S, Prentki M, (1999) Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells. Diabetologia 42: 856-864.
42. Gomez E, Pritchard C, Herbert TP, (2002) cAMP-dependent protein kinase and Ca2+ influx through L-type voltage-gated calcium channels mediate Raf-independent activation of extracellular regulated kinase in response to glucagon-like peptide-1 in pancreatic beta-cells. J Biol Chem 277: 48146-48151.
43. Xu G, Kaneto H, Lopez-Avalos MD, Weir GC, Bonner-Weir S, (2006) GLP-1/exendin-4 facilitates beta-cell neogenesis in rat and human pancreatic ducts. Diabetes Res Clin Pract 73: 107-110.
44. Perfetti R, Zhou J, Doyle ME, Egan JM, (2000) Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 141: 4600-4605.
45. Shu L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH, et al. (2009) Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet 18: 2388-2399.
46. Lin FJ, Qin J, Tang K, Tsai SY, Tsai MJ, (2011) Coup d'Etat: an orphan takes control. Endocr Rev 32: 404-421.
47. Xie X, Qin J, Lin SH, Tsai SY, Tsai MJ, (2011) Nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) modulates mesenchymal cell commitment and differentiation. Proc Natl Acad Sci U S A 108: 14843-14848.
48. Thorens B, (2004) Physiology of GLP-1-Lessons from glucoincretin receptor knockout mice. Horm Metab Res 36: 766-770.
49. Hohmeier H, Mulder H, Chen G, Henkel-Rieger R, Prentki M, et al. (2000) Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and-independent glucose-stimulated insulin secretion. Diabetes 49: 424-430.
50. Oberholzer J, Triponez F, Mage R, Andereggen E, Buhler L, et al. (2000) Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations. Transplantation 69: 1115-1123.
51. Schulthess FT, Paroni F, Sauter NS, Shu L, Ribaux P, et al. (2009) CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab 9: 125-139.
52. Lukowiak B, Vandewalle B, Riachy R, Kerr-Conte J, Gmyr V, et al. (2001) Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem 49: 519-528.
53. Kaiser N, Corcos AP, Sarel I, Cerasi E, (1991) Monolayer culture of adult rat pancreatic islets on extracellular matrix: modulation of B-cell function by chronic exposure to high glucose. Endocrinology 129: 2067-2076.
54. Marshak S, Leibowitz G, Bertuzzi F, Socci C, Kaiser N, et al. (1999) Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 48: 1230-1236.
55. Le Bacquer O, Shu L, Marchand M, Neve B, Paroni F, et al. (2011) TCF7L2 splice variants have distinct effects on beta-cell turnover and function. Hum Mol Genet 20: 1906-1915.
56. Hong JJ, Pan FY, Qian Y, Cheng LC, Zhang HX, et al. (2009) Overexpression of beta-catenin is responsible for the development of portal hypertension during liver cirrhosis. Anat Rec (Hoboken) 292: 818-826.
57. Van Lommel L, Janssens K, Quintens R, Tsukamoto K, Vander Mierde D, et al. (2006) Probe-independent and direct quantification of insulin mRNA and growth hormone mRNA in enriched cell preparations. Diabetes 55: 3214-3220.
58. Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, et al. (2003) NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res 31: 82-86.
59. Duncan DT, Prodduturi N, Zhang B, (2010) WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. BMC Bioinformatics 11: 10.
60. Huang DW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc 4: 44-57.